不稳定性心绞痛的病种费用分析

目的 探讨近两年本院收治的不稳定性心绞痛(ICD10 编码为I20.0) 在平均住院日、住院费用等方面的变化规律,为病种费用控制提供参考.方法 通过医院信息系统(HIS) 抽取满足条件的住院患者费用、用药、材料等信息,计算平均住院日、费用消耗、费用构成等指标,分析该病种的常规用药与治疗措施.结果 该病种2 年平均住院日8.85d,次均住院费4万元左右.材料费占总住院费56.06%.费用前10 位的药品占总药费50.45%,且有7 个品种是辅助用药.结论 不稳定性心绞痛住院人次逐年升高,治疗费用高昂,高值耗材是费用控制的关键;辅助用药比例偏高,存在不合理用药问题.

Cost analysis of unstable angina pectoris

Objective To provide the reference for the control of disease treatment cost by studying the changing rules of average hospital stay time and hospitalization cost in unstable angina pectoris patients(coded as I20.0 in ICD10) admitted to our hospital in the past two years.Methods Data about the cost of drugs and materials in patients meeting requirement were extracted using HIS.The average hospital stay time,total cost,cost structure and other indices were calculated and the routinely-used drugs and treatment measures for the disease were analyzed.Results The average hospital stay time of unstable angina pectoris patients was 8.85 days with a hospitalization cost of about $40,000 each time,and a material cost of 56.06% of the total hospitalization cost.The cost of top-ten expensive drugs including 7 auxiliary drugs accounted for 50.45% of the total drug cost.Conclusion The hospitalization time of unstable angina pectoris patients increases year by year with a considerable treatment cost.Use of high-value consumables is the key to the control of hospitalization cost.The portion of auxiliary drugs is relatively high,which may be due to their irrational use.